Atazanavir
Atazanavir Sulfate, REYATAZ
Protease Inhibitor
NADAC/unit
$1.0882
No Shortage
Tier 1: 77.8%
4 Manufacturers
14 ANDAs
vs. brand Atazanavir Sulfate: Generic saves up to 89% per unit
Active Shortages
2025-06-04 Permanent discontinuation, Bristol Myers Squibb Co.
2025-06-04 Permanent discontinuation, Bristol Myers Squibb Co.
2025-06-04 Permanent discontinuation, Bristol Myers Squibb Co.
Generic Manufacturers
AUROBINDO PHARMA LTDBRISTOL MYERS SQUIBB COHETERO LABS LTD UNIT IIILAURUS LABS LTDTEVA PHARMACEUTICALS USA
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.